Clinical trial
Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian Cancer
NCT07889843 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian Cancer
- Lead sponsor
- Hellenic Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 10, 2026
- Completion date
- April 30, 2027
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
folate receptor alpha positive, high grade serous ovarian cancer
Arms
As registered; 1 arm.
-
Patients with High-Grade Serous Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
This cohort includes approximately 200 eligible female patients aged 18 years or older diagnosed with high-grade serous ovarian, fallopian tube, or primary peritoneal cancer between 1 January 2001 and 30 July 2025. Patients are identified retrospectively from approximately 15 clinical sites in Greece affiliated with the Hellenic Cooperative Oncology Group.
Historically collected Formalin-Fixed Paraffin-Embedded (FFPE) tissue samples obtained at the time of initial diagnosis and stored in the Hellenic Cooperative Oncology Group biobank will be analyzed centrally using the Ventana FOLR1 RxDx assay to determine Folate Receptor Alpha (FRα) expression.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
FRα-Positive Status
Assessment of FRα-positive status at diagnosis, defined as ≥75% of viable tumor cells demonstrating moderate (2+) and/or strong (3+) membrane staining by immunohistochemistry.
Lead sponsor's other trials
Hellenic Cooperative Oncology Group, most recent start first.
+56 more trials See the organization page
Similar trials
Same condition (Ovarian Neoplasms) and phase, most recent start first.
+603 more trials See the condition page